Impact of Hand Rub Placement on Patient Trust and Disease Stigma (NCT07552792) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Impact of Hand Rub Placement on Patient Trust and Disease Stigma
250 participantsStarted 2026-05-01
Plain-language summary
This study aims to investigate how the physical placement of hand sanitizer in consultation rooms affects patient trust and feelings of disease stigma. While hand hygiene is an essential infection control measure in healthcare, performing it immediately in front of patients with visible, non-communicable conditions (such as psoriasis) might inadvertently make patients feel rejected or stigmatized.This study uses a randomized controlled design to evaluate if a simple environmental modification-changing the spatial location of the hand sanitizer-can naturally nudge physicians to alter their hand hygiene timing without compromising safety. Researchers will discreetly observe the hand hygiene behavior of outpatient dermatologists and ask participating psoriasis patients to complete a brief, anonymous questionnaire regarding their trust in the physician, feelings of stigma, and overall satisfaction with the consultation. The goal is to provide evidence for patient-centered hospital space designs that protect patient psychological well-being while maintaining hygiene standards.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
For Patients:
* Aged 18 years or older.
* Diagnosed with psoriasis and receiving treatment at the designated psoriasis specialty outpatient clinic during the study period.
* Legally capable of signing the informed consent form and cognitively able to understand and complete the questionnaire (independently or with assistance from family members).
For Physicians:
* Hold a registered practicing qualification in the Dermatology Department of Huashan Hospital Pudong Branch and are qualified for independent outpatient consultations.
* Scheduled to continuously undertake outpatient work in the designated consultation rooms during the study period.
* Voluntarily sign the informed consent form for behavioral observation.
Exclusion Criteria:
For Patients:
* Severe visual, hearing, or speech impairments leading to basic doctor-patient communication barriers.
* Diagnosed with psychiatric disorders (e.g., schizophrenia, severe depression) that, as assessed by a specialist, may interfere with the authenticity of the questionnaire responses.
* Presenting with a clinical state requiring emergency treatment during the visit, such as acute infection of skin lesions or generalized pustules.
For Physicians:
* Non-permanent practicing staff of the hospital, such as visiting physicians or rotating medical students.
* Unable to independently perform hand hygiene procedures due to physical/limb dysfunction.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Proportion of Invisible Hand Hygiene Events
Timeframe: Assessed during the outpatient consultation (average 10-15 minutes per consultation).
2
Patient Trust in Physician Scale (TPS) Score
Timeframe: Assessed immediately after the outpatient consultation.
3
Feelings of Stigma Questionnaire (FSQ) Score
Timeframe: Assessed immediately after the outpatient consultation.